KMI announces strategic distribution agreement with Mobility to market stroke therapy devices

NewsGuard 100/100 Score

Kinetic Muscles Inc. (“KMI”) (www.kineticmuscles.com), a leading developer of stroke therapy technology, today announced a strategic distribution agreement with Mobility Research (“Mobility”), also of Tempe, that will allow Mobility to market KMI’s products in specific international markets.

“Mobility is respected throughout the therapy industry, with an extensive international distribution network and more than 4,000 worldwide clinical installations of the LiteGait® System”

KMI manufactures the innovative Hand Mentor and Foot Mentor stroke therapy devices. Mobility is a global leader with their highly successful LiteGait® Partial-Weight-Assisted Treadmill System. It is used for rehabilitation therapy to assist in the recovery of walking function.

“Mobility is respected throughout the therapy industry, with an extensive international distribution network and more than 4,000 worldwide clinical installations of the LiteGait® System,” said Grant Farrell, president and CEO of KMI, in announcing the agreement.

“This partnership provides an excellent opportunity for KMI to broaden deployment of our products while we continue to focus on our revolutionary ‘Virtual Clinic’ in-home stroke therapy system,” said Farrell.

"The addition of KMI’s world-class products to our lineup makes it easier for our distributors to provide their thousands of customers with a total rehab solution," said Steve Martinez, Director of Sales and Marketing for Mobility Research. "We believe KMI’s solutions will perfectly complement our commitment to provide people the best therapy possible at an affordable price."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Opportunistic atrial fibrillation screening key to preventing strokes